DOCSLIB.ORG

Designated Lists Can Be Viewed Here

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

INGREDIENT DISCLOSURE 7055 Lindell Rd, Las Vegas, NV 89118 800.293.4698 | www.bradyindustries.com Ingredient Disclosure Designated List Links SB 258, Cleaning Product Right to Know Act of 2017 List Description 1 CA Prop 65 2 EU CMRs 3 EU Endocrine Disruptors 4 IRIS Neurotoxicants 5 IRIS Carcinogens 6 EU PBTs 7 Canada PBTs 8 EU Respiratory Sensitizers 9 IARC Carcinogens 10 ATSDR Neurotoxicants 11 US EPA Priority Chemicals List 12 US NTP Reproductive or Developmental Toxicants 13 US EPA PBTs 14 WA PBTs 15 US NTP Carcinogens 16 CA NLs 17 CA MCLs 18 CA TACs 19 CA Priority Pollutants 20 CA Non-Cancer Hazards 21 CA Priority Chemicals 22 Marine Priority Action Chemicals 23 EU Fragrance Allergens NFC Nonfunctional Constituents N/A Not Applicable Fragrance Allergen Ingredient CHEMICAL NAME CAS NUMBER 1-Phenylethanone 98-86-2 3-(1,3-Benzodioxol-5-yl)-2-methylpropanal 1205-17-0 Acetaldehyde 75-07-0 a-Isomethyl ionone 127-51-5 Amyl Cinnamal 122-40-7 AmylCinnamyl Alcohol 101-85-9 Anise Alcohol 105-13-5 Benzophenone 119-61-9 Benzyl alcohol 100-51-6 Benzyl benzoate 120-51-4 Benzyl Cinnamate 103-41-3 Benzyl Salicylate 118-58-1 BHA 25013-16-5 Biphenyl 92-52-4 Butylphenyl Methylpropional (Lilial) 80-54-6 Cinnamal 104-55-2 Cinnamyl Alcohol 104-54-1 Citral 5392-40-5 Citronellol 106-22-9 Citronellol (3,7-Dimethyloct-6-en-1-ol) 106-22-9 Coumarin 91-64-5 Cyclotetrasiloxane 556-67-2 Diethyl phthalate 84-66-2 Estragole (1-Allyl-4-methoxybenzene) 140-67-0 Eugenol (4-Allyl-2-methoxyphenol) 97-53-0 Farnesol 4602-84-0 Geraniol 106-24-1 Hexanedioic Acid, Bis(2-ethylhexyl) Ester 103-23-1 Hexyl cinnamaldehyde 101-86-0 Hydroxycitronellal 107-75-5 Hydroxyisohexyl 3-cyclohexene carboxalderhyde 31906-04-4 Isobutenyl Methyltetrahydropyran 16409-43-1 IsoEugenol (2-Methoxy-4-prop-1-en-1-ylphenol ) 97-54-1 Isopropyl Alcohol 67-63-0 Limonene 5989-27-5 Linalool 78-70-6 Methyl Eugenol 93-15-2 Methyl-2-Octynoate 111-12-6 Musk Ketone 81-14-1 Myrcene (7-Methyl-3-methyleneocta-1,6-diene ) 123-35-3 OakMoss (Evernia PrusnasTri Extract) 90028-68-5 p-Crestol 106-44-5 Phenol 108-95-2 p-Methylanisole 104-93-8 Propionaldehyde 123-38-6 Pulegone (2-Isopropylidene-5-methylcyclohexanone) 89-82-7 TreeMoss (Evernia Furfuracea Extract) 90028-67-4 Evernia prunastri (Oakmoss) 9000-50-4 Safrole 94-59-7 Cinnamomum Cassia Leaf Oil 8015-91-6 Poly (oxy-1,2-ethanediyl,&a;-(4-nonylphenyl)-ω-hydroxy-branched127087-87-0 Treemoss Absolute (Pseudevernia Furfuracea) 68648-41-9 CAS Number IUPAC Name/Chemical Name/Essential Oil 77-53-2 (1S,2R,5S,7S,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecan-8-ol 101-48-4 (2,2-Dimethoxyethyl)benzene 13828-37-0 (4-Isopropylcyclohexyl)methanol 4395-92-0 (4-Isopropylphenyl)acetaldehyde 105-13-5 (4-Methoxyphenyl)methanol 58567-11-6 (Ethoxymethoxy)cyclododecane 7492-67-3 [(3,7-Dimethyloct-6-en-1-yl)oxy]acetaldehyde 54464-57-2 1-(2,3,8,8-Tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone 39872-57-6 1-(2,4,4-Trimethylcyclohex-2-en-1-yl)but-2-en-1-one 144020-22-4 1-(2,5,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone 23726-91-2 1-(2,6,6-Trimethylcyclohex-1-en-1-yl)but-2-en-1-one 24720-09-0 1-(2,6,6-Trimethylcyclohex-2-en-1-yl)but-2-en-1-one 79-78-7 1-(2,6,6-Trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one 1335-46-2 1-(2,6,6-Trimethylcyclohex-2-en-1-yl)pent-1-en-3-one 23696-85-7 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one 93-08-3 1-(2-Naphthyl)ethanone 139504-68-0 1-(2-tert.-Butyl cyclohexyloxy)-2-butanol 25225-08-5 1-(3,3-Dimethylcyclohexyl)ethyl formate 1506-02-1 1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone 122-00-9 1-(4-Methylphenyl)ethanone 81-14-1 1-(4-tert-Butyl-2,6-dimethyl-3,5-dinitrophenyl)ethanone 13171-00-1 1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone 33704-61-9 1,1,2,3,3-Pentamethyl-1,2,3,5,6,7-hexahydro-4H-inden-4-one 151-05-3 1,1-Dimethyl-2-phenylethyl acetate 10094-34-5 1,1-Dimethyl-2-phenylethyl butyrate 1118-39-4 1,1-Dimethyl-5-methylenehept-6-en-1-yl acetate 101-84-8 1,1'-Oxydibenzene 25265-71-8 1,1'-Oxydipropan-1-ol 93-16-3 1,2-Dimethoxy-4-prop-1-en-1-ylbenzene 470-82-6 1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octane 1632-73-1 1,3,3-Trimethylbicyclo[2.2.1]heptan-2-ol 1195-79-5 1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one 120-57-0 1,3-Benzodioxole-5-carbaldehyde 105-95-3 1,4-Dioxacycloheptadecane-5,17-dione 78-35-3 1,5-Dimethyl-1-vinylhex-4-en-1-yl 2-methylpropanoate 115-95-7 1,5-Dimethyl-1-vinylhex-4-en-1-yl acetate 144-39-8 1,5-Dimethyl-1-vinylhex-4-en-1-yl propionate 125-12-2 1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl acetate 5655-61-8 1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl acetate 124-76-5 1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol 76-22-2 1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one 107-74-4 1,7-Octanediol, 3,7-dimethyl- 140-67-0 1-Allyl-4-methoxybenzene (Estragole) 32388-55-9 1-Cedr-8-en-9-ylethanone 67633-95-8 1-Hydroxydecan-3-one 99-87-6 1-Isopropyl-4-methylbenzene 104-93-8 1-Methoxy-4-methylbenzene 4180-23-8 1-Methoxy-4-prop-1-en-1-ylbenzene 52475-86-2 1-Methyl-4-(4-methylpent-3-en-1-yl)cyclohex-3-ene-1-carbaldehyde 98-85-1 1-Phenylethanol 98-86-2 1-Phenylethanone 93-92-5 1-Phenylethyl acetate 104-67-6 2(3H)-Furanone, 5-heptyldihydro- 98-55-5 2-(4-Methylcyclohex-3-en-1-yl)propan-2-ol 1365-19-1 2-(5-Methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol 90-17-5 2,2,2-Trichloro-1-phenylethyl acetate 5182-36-5 2,4,6-Trimethyl-4-phenyl-1,3-dioxane 68039-49-6 2,4-Dimethylcyclohex-3-ene-1-carbaldehyde 80-56-8 2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene 106-72-9 2,6-Dimethylhept-5-enal 13254-34-7 2,6-Dimethylheptan-2-ol 18479-58-8 2,6-Dimethyloct-7-en-2-ol 18479-57-7 2,6-Dimethyloctan-2-ol 128-37-0 2,6-Di-tert-butyl-4-methylphenol 141-12-8 2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (Z)- 122-40-7 2-Benzylideneheptanal 101-86-0 2-Benzylideneoctanal 57378-68-4 2-Buten-1-one, 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)- 68845-36-3 2-Cyclohexen-1-one, diethyldimethyl- 94-86-0 2-Ethoxy-5-prop-1-en-1-ylphenol 93-18-5 2-Ethoxynaphthalene 4940-11-8 2-Ethyl-3-hydroxy-4H-pyran-4-one 91-64-5 2H-Chromen-2-one 476332-65-7 2H-Indeno[4,5b] furan, decahydro-2,2,6,6,7,8,8-heptamethyl 63500-71-0 2H-Pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl)- 80-71-7 2-Hydroxy-3-methylcyclopent-2-en-1-one 89-79-2 2-Isopropenyl-5-methylcyclohexanol 2216-51-5 2-Isopropyl-5-methylcyclohexanol 491-07-6 2-Isopropyl-5-methylcyclohexanone 89-80-5 2-Isopropyl-5-methylcyclohexanone 89-48-5 2-Isopropyl-5-methylcyclohexyl acetate 89-82-7 2-Isopropylidene-5-methylcyclohexanone (Pulegone) 97-54-1 2-Methoxy-4-prop-1-en-1-ylphenol 93-29-8 2-Methoxy-4-prop-1-en-1-ylphenyl acetate 93-04-9 2-Methoxynaphthalene 100-86-7 2-Methyl-1-phenylpropan-2-ol 65416-14-0 2-Methyl-4-oxo-4H-pyran-3-yl 2-methylpropanoate 103-05-9 2-Methyl-4-phenylbutan-2-ol 3142-72-1 2-Methylpent-2-enoic acid 110-41-8 2-Methylundecanal 122-99-6 2-Phenoxyethanol 103-60-6 2-Phenoxyethyl 2-methylpropanoate 23495-12-7 2-Phenoxyethyl propionate 60-12-8 2-Phenylethanol 103-48-0 2-Phenylethyl 2-methylpropanoate 103-45-7 2-Phenylethyl acetate 102-20-5 2-Phenylethyl phenylacetate 88-41-5 2-t-Butylcyclohexyl acetate 1205-17-0 3-(1,3-Benzodioxol-5-yl)-2-methylpropanal 67634-14-4 3-(2-Ethylphenyl)-2,2-dimethylpropanal 103-95-7 3-(4-Isopropylphenyl)-2-methylpropanal 6658-48-6 3-(4-Isopropylphenyl)-2-methylpropanal 18127-01-0 3-(4-tert-Butylphenyl)propanal 3407-42-9 3-(5,5,6-Trimethylbicyclo[2.2.1]hept-2-yl)cyclohexanol 61792-11-8 3,7-Dimethylnona-2,6-dienenitrile 106-22-9 3,7-Dimethyloct-6-en-1-ol 150-84-5 3,7-Dimethyloct-6-en-1-yl acetate 105-85-1 3,7-Dimethyloct-6-en-1-yl formate 106-23-0 3,7-Dimethyloct-6-enal 51566-62-2 3,7-Dimethyloct-6-enenitrile 78-70-6 3,7-Dimethylocta-1,6-dien-3-ol 106-25-2 3,7-Dimethylocta-2,6-dien-1-ol 105-87-3 3,7-Dimethylocta-2,6-dien-1-yl acetate 105-86-2 3,7-Dimethylocta-2,6-dien-1-yl formate 5392-40-5 3,7-Dimethylocta-2,6-dienal 106-21-8 3,7-Dimethyloctan-1-ol 78-69-3 3,7-Dimethyloctan-3-ol 5988-91-0 3,7-Dimethyloctanal 54830-99-8 3a,4,5,6,7,7a-Hexahydro-1H-4,7-methanoinden-1-yl acetate 17511-60-3 3a,4,5,6,7,7a-Hexahydro-1H-4,7-methanoinden-6-yl propionate 14901-07-6 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- 21690-43-7 3-Cyclohexene-1-carbonitrile, 4-(4-methyl-3-pentenyl)- 81782-77-6 3-Decen-5-ol, 4-methyl- 121-32-4 3-Ethoxy-4-hydroxybenzaldehyde 118-71-8 3-Hydroxy-2-methyl-4h-pyran-4-one 1128-08-1 3-Methyl-2-pentylcyclopent-2-en-1-one 127-51-5 3-Methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one 65113-99-7 3-Methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol 55066-48-3 3-Methyl-5-phenylpentan-1-ol 1191-16-8 3-Methylbut-2-en-1-yl acetate 123-51-3 3-Methylbutan-1-ol 659-70-1 3-Methylbutyl 3-methylbutanoate 123-92-2 3-Methylbutyl acetate 106-27-4 3-Methylbutyl butyrate 105-68-0 3-Methylbutyl propionate 18871-14-2 3-O-Acetyl-1,5-anhydro-2,4-dideoxy-2-pentylpentitol 104-55-2 3-Phenylacrylaldehyde 104-54-1 3-Phenylprop-2-en-1-ol 103-54-8 3-Phenylprop-2-en-1-yl acetate 122-97-4 3-Phenylpropan-1-ol 8013-90-9 4-(2,6,6-Trimethylcyclohex-1-en-1-yl)but-3-en-2-one 127-41-3 4-(2,6,6-Trimethylcyclohex-2-en-1-yl)but-3-en-2-one 31906-04-4 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde 5471-51-2 4-(4-Hydroxyphenyl)butan-2-one 87-44-5 4,11,11-Trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene 18096-62-3 4,4a,5,9b-Tetrahydroindeno[1,2-d][1,3]dioxine 1335-66-6 4,5,6-Trimethylcyclohex-3-ene-1-carbaldehyde 1222-05-5 4,6,6,7,8,8-Hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene 97-53-0 4-Allyl-2-methoxyphenol 3658-77-3 4-Hydroxy-2,5-dimethylfuran-3(2H)-one 121-33-5 4-Hydroxy-3-methoxybenzaldehyde 122-03-2 4-Isopropylbenzaldehyde 586-62-9 4-Isopropylidene-1-methylcyclohexene
Recommended publications
  • U.S. EPA, Pesticide Product Label, WHITE CAP 15% PINE OIL

    U.S. EPA, Pesticide Product Label, WHITE CAP 15% PINE OIL

    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY /0 -c:JJ - cXJ{X).. EPA Reg. Date of Issuance: U.S . ENVIRONMENTAL PRCTECTION AGENCY Number: .,-«0 $7'.-, Office of ?esticide Programs ~. ~ ~ Antimicrob:a:s Division (7510C] 72138-E 1200 Penns:(:.vania Avenue N.W. OCT 2 1 201a {$1V:Z ~ Washir:g:on, D.C. 20460 <>.,J Term of IS~..lance: NOTICE OF PESTICIDE: Conditional _x_ Registration Reregistration --- Name of Pe~:icide Product: White (under fH'RA, as amended) Cap 15% Pine Oil Cleaner/Disinfectant Name and Address of Registrant (inc! ude lIP Code): White Cap, Inc. 625 Governor Printz Blvd. lC""'i.ngton, PA 19029 .0": Changes. in 1~1~ e~~t . :li1 silbstance from that accepted in connection witlt this registration must be _.-tted t:l'I!ondacd . -,,-~~~~~~_J..strat10n 01vbion prior to use of the label ia c01MIerce. In any correspondeQoe " : _ _ rater -to. the above EPA registration number. On the basis of information furnished by the registrant, the above named pesticide is hereby registered/reregistered under the Federal Insecticide, Fungicide and Rodenticide Act. Registration is in no way to be construed as an endorsement or recommendation of this product by the Agency. In order to protect health and the environment, the Administrator, on his motion, may at any time suspend or cancel the registration of a pesticide in accordance with the Act. The acceptance of any name in connection with the registration of a product under this Act is not to be construed as giving the registrant a right to exclusive use of the name or to its use if it has been covered by others.
  • An Artifact in a Synthetic Pine Oil

    An Artifact in a Synthetic Pine Oil

    RESEARCH NOTE J. Ess. Oil Res., 3, 41-42 (Jan/Feb 1991) An Artifact in a Synthetic Pine Oil Duane F. Zinkel USDA Forest Service, Forest Products Laboratory* One Gifford Pinchot Drive Madison, WI 53705-2398 ABSTRACT: The isopropyl ether of a-terpineol was identified as an artifact in the synthetic pine oil produced when isopropyl alcohol was used as the emulsifier. KEY WORD INDEX: Synthetic pine oil, a-terpineol isopropyl ether, terpinen-4-ol isopropyl ether, turpentine. INTRODUCTION: The manufacture of synthetic pine oil is the primary use for turpentine. The synthesis involves the acid-catalyzed hydration of a-pinene at the in­ terface ofan emulsion of pinene/mineral acid (1). Various emulsifiers have been used, one of which is isopropyl alcohol. Our gas chromatographic examination of a commercial distilled pine oil, produced using the isopropyl alcohol emulsifier, revealed the presence of 4-5% of a higher boiling component product not present originally in the turpentine. EXPERIMENTAL: NMR spectra were obtained at 310 K with a Bruker WM250 (250 MHz proton and 62.9 MHz carbon) FT spectrometer controlled by an Aspect 2000A minicomputer; DEPT spectra were obtained with a standard Bruker program. Gas chromatography was done with a Hewlett Packard 5880 gas chromatograph (FID) and fused-silica columns: a DB-1 (a methyl silicone) column from J & W Scientific (Folsom, CA), 15m x 0.25mmi.d. witha 0.1-µmfilmoperatedat60°Cand a Carbowaxcolumn,30m x 0.25mm with a 0.25-µm film temperature programmed from 60°C to 225°C at 8°C/min. isopropyl etherwas isolated by liquid chromatography.
  • (12) United States Patent (10) Patent No.: US 6,239,087 B1 Mao Et Al

    (12) United States Patent (10) Patent No.: US 6,239,087 B1 Mao Et Al

    USOO6239087B1 (12) United States Patent (10) Patent No.: US 6,239,087 B1 Mao et al. (45) Date of Patent: May 29, 2001 (54) DETERGENT COMPOSITIONS (56) References Cited CONTAINING FRAGRANCE PRECURSORS U.S. PATENT DOCUMENTS AND THE FRAGRANCE PRECURSORS THEMSELVES 2,448,660 9/1948 Croxall et al. ....................... 568/600 2,490,337 12/1949 Croxall et al. ....................... 568/594 (75) Inventors: Hsiang Kuen Mao, Kobe (JP); Joseph 5,288,423 * 2/1994 Behan et al...... ... 252/174.11 Paul Morelli; Henry Cheng Na, both 5,447,644 9/1995 Guenin et al. ........................ 252/8.6 5,500,138 3/1996 Bacon et al. ......................... 510/102 of Cincinnati, OH (US); Robert Ya-Lin 5,500,154 3/1996 Bacon et al. ......................... 510/102 Pan, Kobe (JP); Mark Robert Sivik, 5,656,584 * 8/1997 Angell et al. ........................ 510/441 Fairfield, OH (US) 5,668,862 9/1997 Price et al. ........................... 568/594 (73) Assignee: The Procter & Gamble Company, 5,731,282 3/1998 Duquesne ............................. 510/423 Cincinnati, OH (US) OTHER PUBLICATIONS Rothman et al., “Enol Esters XVI: Enol Ethers in Synthe Notice: Subject to any disclaimer, the term of this sis”: Eastern Regional Research Laboratory, Philadelphia, patent is extended or adjusted under 35 Pennsyvania, pp. 376-377, (Jun. 1972). U.S.C. 154(b) by 0 days. Dejarlais et al., “Preparation of Some Ethyl Higher-Alkyl Appl. No.: 09/155,140 Acetals and Their Conversion to Vinyl Ethers': Northern (21) Regional Research Laboratory, Peoria, Illinois, pp. 241-243, (22) PCT Fed: Mar. 22, 1996 (May 1961). (86) PCT No.: PCT/US96/04060 * cited by examiner S371 Date: Sep.
  • Effect of Curcumin, Mixture of Curcumin and Piperine and Curcum (Turmeric) on Lipid Profile of Normal and Hyperlipidemic Rats

    Effect of Curcumin, Mixture of Curcumin and Piperine and Curcum (Turmeric) on Lipid Profile of Normal and Hyperlipidemic Rats

    The Egyptian Journal of Hospital Medicine Vol., 21: 145 – 161 December 2005 I.S.S.N: 12084 2002–1687 Effect of Curcumin, Mixture of Curcumin and Piperine and Curcum (Turmeric) on Lipid Profile of Normal and Hyperlipidemic Rats GHADA, Z. A. Soliman Lecturer of Biochemistry, Biochemistry Department, National Nutrition Institute, Cairo Abstract Curcumin is a polyphenolic, yellow pigment obtained from rhizomes of Curcuma longa (curcum), used as a spice and food colouring. The extracts have several pharmacological effects. We evaluated the effect of curcum, curcumin, and mixture of curcumin and piperine on plasma lipids in normal and hypercholesterolemic rats. A total of 270 rats, divided into 27 groups, were used. G1, G11: control, G2-G11: normal rats fed control diet supplemented with different levels of curcumin and curcum (G2-G6: 0.1%, 0.25%, 0.5%, 1.0%, 2.0% respectively, G7-G11: 1.67%, 4.167%, 8.34%, 16.67%, and 33.34). G12-G26: at first fed control diet supplemented with 2% cholesterol then G13-17, 21-25 fed a control diet supplemented with different levels of curcumin, and curcum [the same levels as G2-G11; G18-20 fed control diet supplemented with mixture of curcumin (0.1, 0.25, 0.5%) and piperine (20 mg/kg BW)], G12 was sacrificed before addition of studied materials, G26 were fed control diet. Lipid profile, triacylglycerol and phospholipids of plasma and organs as liver and heart were measured. Serum cholesterol (total, LDL-C, VLDL-C), triacylglycerol and phospholipids contents were elevated in cholesterol-fed rats, while HDL-C were decreased.
  • Mechanistic Study of Physicochemical and Biochemical Processes

    Mechanistic Study of Physicochemical and Biochemical Processes

    Mechanistic study of physicochemical and biochemical processes affecting intestinal absorption of the sesquiterpene lactone nobilin from multi-component systems in the Caco-2 model. Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von URSULA STEPHANIE THORMANN aus Bern (BE) Basel, 2015 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Dieses Werk ist unter dem Vertrag „Creative Commons Namensnennung-Keine kommerzielle Nutzung-Keine Bearbeitung 3.0 Schweiz“ (CC BY-NC-ND 3.0 CH) lizenziert. Die vollständige Lizenz kann unter creativecommons.org/licenses/by-nc-nd/3.0/ch/eingesehen werden. Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. G. Imanidis und Prof. Dr. H. E. U. Meyer zu Schwabedissen Basel, den 18. Februar 2014 Prof. Dr. J. Schibler Namensnennung-Keine kommerzielle Nutzung-Keine Bearbeitung 3.0 Schweiz (CC BY-NC-ND 3.0 CH) Sie dürfen: Teilen — den Inhalt kopieren, verbreiten und zugänglich machen Unter den folgenden Bedingungen: Namensnennung — Sie müssen den Namen des Autors/Rechteinhabers in der von ihm festgelegten Weise nennen. Keine kommerzielle Nutzung — Sie dürfen diesen Inhalt nicht für kommerzielle Zwecke nutzen. Keine Bearbeitung erlaubt — Sie dürfen diesen Inhalt nicht bearbeiten, abwandeln oder in anderer Weise verändern. Wobei gilt: Verzichtserklärung — Jede der vorgenannten Bedingungen kann aufgehoben werden, sofern Sie die
  • Pine DC Plus™ Disinfectant Cleaner a One-Step Disinfectant Cleaner That Is Effective in the Reduction of Cross-Contamination

    Pine DC Plus™ Disinfectant Cleaner a One-Step Disinfectant Cleaner That Is Effective in the Reduction of Cross-Contamination

    Pine DC Plus™ Disinfectant Cleaner A one-step disinfectant cleaner that is effective in the reduction of cross-contamination. Units Item # Description Size Per Case BPR460001-A Pine DC Plus™ Gallon 4 Features • Formulated as a one-step cleaner/disinfectant • Kills Trichophyton Mentagrophytes (Athlete’s foot fungus) • Neutral pH does not dull floor finishes when diluted correctly • Hospital grade to meet strict requirements • Quat formula has broad spectrum efficacy • Contains no phosphates to reduce pollution of waterways • Effective against the HIV-1 (AIDS Virus) when used on previously • EPA-registered formula confirms efficacy compliance cleaned surfaces • Pleasant pine oil fragrance • Powerful cleaning, deodorizing and disinfecting performance Order today at Order.StaplesAdvantage.com, EWay.comTM, CoastwideLabs.com, or your online ordering system. Pine DC Plus™ One-Step Germicidal Detergent A one-step disinfectant cleaner that is effective against a broad spectrum of bacteria and viruses and inhibits the growth of mold and mildew. When used as directed, Pine DC Plus will deodorize surfaces in toilet areas, behind and under sinks and counter, garbage cans and garbage storage areas, and other places where bacterial growth can cause malodors. Recommended for use in hospitals, public restrooms, athletic facilities, restaurants and bars, airports, hotels and motels. Contains no phosphorous. Pine DC Plus is a no-rinse neutral pH disinfectant cleaner that disinfects, cleans and deodorizes in one labor-saving step. Provides effective cleaning strength that will not dull most metal-interlock floor finishes, and does not require a rinse prior to recoat. Pine DC Plus is recommended for nonscratch cleaning of showers and tubs, shower doors and curtains, fixtures and toilet bowls.
  • Impact of Lipid Sources on Quality Traits of Medical Cannabis-Based Oil Preparations

    Impact of Lipid Sources on Quality Traits of Medical Cannabis-Based Oil Preparations

    Article Impact of Lipid Sources on Quality Traits of Medical Cannabis-Based Oil Preparations Alberto Ramella 1, Gabriella Roda 2, Radmila Pavlovic 3,*, Michele Dei Cas 4, Eleonora Casagni 2, Giacomo Mosconi 3, Francisco Cecati 5, Paola Minghetti 2 and Carlo Grizzetti 6 1 Farmacia Dott.ri Giuliana e Alberto Ramella–SAS, Via A. Diaz 1, 21021 Angera (VA), Italy; [email protected] 2 Department of Pharmaceutical Sciences, Università degli Studi di Milano, Via L. Mangiagalli 25, 20133 Milan, Italy; [email protected] (G.R.); [email protected] (E.C.); [email protected] (P.M.) 3 Department of Health, Animal Science and Food Safety, University of Milan, 20133 Milan, Italy; [email protected] 4 Department of Health Sciences, Università degli Studi di Milano, Via A.di Rudinì 8, 20142 Milan, Italy; [email protected] 5 INTEQUI-CONICET, Faculty of Chemistry, Biochemistry and Pharmacy, National University of San Luis, Almirante Brown 1455, CP 5700 San Luis, Argentina; [email protected] 6 S.S.D. Cure Palliative e Terapia del Dolore, Ospedale di Circolo–Fondazione Macchi, ASST Sette Laghi, Viale L. Borri 57, 21100 Varese, Italy; [email protected] * Correspondence: [email protected] Academic Editor: Maria Carla Marcotullio Received: 2 June 2020; Accepted: 29 June 2020; Published: 30 June 2020 Abstract: The feasibility of the use of two lipid sources and their impact on the cannabinoid profile, terpene fingerprint, and degradation products in medical cannabis oil preparations during 3 months of refrigerated storage time were investigated. LCHRMS-Orbitrap® and HS-SPME coupled to GC- MS for the investigation of targeted and untargeted cannabinoids, terpenes, and lipid degradation products in Bedrocan® and Bediol® macerated oils were used as analytical approaches.
  • Phospholipid Metabolism in Stimulated Human Platelets: CHANGES in PHOSPHATIDYLINOSITOL, PHOSPHATIDIC ACID, and LYSOPHOSPHOLIPIDS

    Phospholipid Metabolism in Stimulated Human Platelets: CHANGES in PHOSPHATIDYLINOSITOL, PHOSPHATIDIC ACID, and LYSOPHOSPHOLIPIDS

    Phospholipid Metabolism in Stimulated Human Platelets: CHANGES IN PHOSPHATIDYLINOSITOL, PHOSPHATIDIC ACID, AND LYSOPHOSPHOLIPIDS M. Johan Broekman, … , Jean W. Ward, Aaron J. Marcus J Clin Invest. 1980;66(2):275-283. https://doi.org/10.1172/JCI109854. Endogenous phospholipid metabolism in stimulated human platelets was studied by phosphorus assay of major and minor components following separation by two-dimensional thin-layer chromatography. This procedure obviated the use of radioactive labels. Extensive changes were found in quantities of phosphatidylinositol (PI) and phosphatidic acid (PA) as a consequence of thrombin or collagen stimulation. Thrombin addition was followed by rapid alterations in the amount of endogenous PI and PA. The decrease in PI was not precisely reciprocated by an increase in PA when thrombin was the stimulus. This apparent discrepancy could be explained by removal of a transient intermediate in PI metabolism, such as diglyceride, formed by PI-specific phospholipase C (Rittenhouse-Simmons, S., J. Clin. Invest.63: 580-587, 1979). Diglyceride would be unavailable for PA formation by diglyceride kinase, if hydrolyzed by diglyceride lipase (Bell, R. L., D. A. Kennerly, N. Stanford, and P. W. Majerus. Proc. Natl. Acad. Sci. U. S. A.76: 3238-3241, 1979) to yield arachidonate for prostaglandin endoperoxide formation. Thrombin-treated platelets also accumulated lysophospho-glycerides. Specifically, lysophosphatidyl ethanolamines accumulated within 15s following thrombin addition. Fatty acid and aldehyde analysis indicated phospholipase A2 activity, with an apparent preference for diacyl ethanolamine phosphoglycerides. In the case of collagen, these changes occurred concomitantly with aggregation and consumption of oxygen for prostaglandin endoperoxide formation. These studies of endogenous phospholipid metabolism provide information supporting the existence of […] Find the latest version: https://jci.me/109854/pdf Phospholipid Metabolism in Stimulated Human Platelets CHANGES IN PHOSPHATIDYLINOSITOL, PHOSPHATIDIC ACID, AND LYSOPHOSPHOLIPIDS NI.
  • Positive Allosteric Modulators (Pams) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain

    Positive Allosteric Modulators (Pams) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain

    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain Jayden Elmer Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Behavioral Neurobiology Commons, Behavior and Behavior Mechanisms Commons, Medicinal and Pharmaceutical Chemistry Commons, Nervous System Diseases Commons, and the Pharmacology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/6777 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain Jayden A. Elmer Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University By Jayden Aric Elmer Bachelor of Science, University of Virginia, 2018 Director: Dr. Aron Lichtman, Professor, Department of Pharmacology & Toxicology; Associate Dean of Research and Graduate Studies, School of Pharmacy Virginia Commonwealth University Richmond, Virginia July 2021 Acknowledgements I would first like to extend my gratitude towards the CERT program at VCU. The CERT program opened the doors for me to get involved in graduate research.
  • Complementary Analytical Platforms of NMR Spectroscopy and LCMS Analysis in the Metabolite Profiling of Isochrysis Galbana

    Complementary Analytical Platforms of NMR Spectroscopy and LCMS Analysis in the Metabolite Profiling of Isochrysis Galbana

    marine drugs Article Complementary Analytical Platforms of NMR Spectroscopy and LCMS Analysis in the Metabolite Profiling of Isochrysis galbana Muhammad Safwan Ahamad Bustamam 1, Hamza Ahmed Pantami 2 , Awanis Azizan 1 , Khozirah Shaari 1,2, Chong Chou Min 3, Faridah Abas 1 , Norio Nagao 3, Maulidiani Maulidiani 4, Sanjoy Banerjee 1, Fadzil Sulaiman 1 and Intan Safinar Ismail 1,2,* 1 Natural Medicine and Products Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia; [email protected] (M.S.A.B.); [email protected] (A.A.); [email protected] (K.S.); [email protected] (F.A.); [email protected] (S.B.); [email protected] (F.S.) 2 Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia; [email protected] 3 Department of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia; [email protected] (C.C.M.); [email protected] (N.N.) 4 Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus 21030, Terengganu, Malaysia; [email protected] * Correspondence: safi[email protected]; Tel.: +60-3-9769-7492 Abstract: This study was designed to profile the metabolites of Isochrysis galbana, an indigenous and Citation: Bustamam, M.S.A.; less explored microalgae species. 1H Nuclear Magnetic Resonance (NMR) spectroscopy and Liquid Pantami, H.A.; Azizan, A.; Shaari, K.; Chromatography-Mass Spectrometry (LCMS) were used to establish the metabolite profiles of five Min, C.C.; Abas, F.; Nagao, N.; different extracts of this microalga, which are hexane (Hex), ethyl acetate (EtOAc), absolute ethanol Maulidiani, M.; Banerjee, S.; (EtOH), EtOH:water 1:1 (AqE), and 100% water (Aq).
  • 2010 National Ambulatory Medical Care Survey Public Use Data File

    2010 National Ambulatory Medical Care Survey Public Use Data File

    2010 NAMCS MICRO-DATA FILE DOCUMENTATION PAGE 1 ABSTRACT This material provides documentation for users of the 2010 National Ambulatory Medical Care Survey (NAMCS) public use micro-data file. NAMCS is a national probability sample survey of visits to office-based physicians conducted by the National Center for Health Statistics, Centers for Disease Control and Prevention. It is a component of the National Health Care Surveys which measure health care utilization across a variety of health care providers. Section I, "Description of the National Ambulatory Medical Care Survey," includes information on the scope of the survey, the sample, field activities, data collection procedures, medical coding procedures, population estimates, and sampling errors. Section II provides technical information, including a detailed description of the contents of each data record by location, and a list of physician specialties represented in the survey. Section III contains marginal data and estimates for selected items on the data record. The appendixes contain sampling errors, instructions and definitions for completing the Patient Record form, and lists of codes used in the survey. PAGE 2 2010 NAMCS MICRO-DATA FILE DOCUMENTATION SUMMARY OF CHANGES FOR 2010 The 2010 NAMCS public use micro-data file is, for the most part, similar to the 2009 file, but there are some important changes. These are described in more detail below and reflect changes to the survey instruments, the Patient Record form and the Physician Induction Interview form. There are also new injury-related items on the public use file, but these are simply recoded data from existing items on the Patient Record form and are described in a separate section below.
  • Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008

    Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008

    Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 William A. Rutala, Ph.D., M.P.H.1,2, David J. Weber, M.D., M.P.H.1,2, and the Healthcare Infection Control Practices Advisory Committee (HICPAC)3 1Hospital Epidemiology University of North Carolina Health Care System Chapel Hill, NC 27514 2Division of Infectious Diseases University of North Carolina School of Medicine Chapel Hill, NC 27599-7030 1 Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 3HICPAC Members Robert A. Weinstein, MD (Chair) Cook County Hospital Chicago, IL Jane D. Siegel, MD (Co-Chair) University of Texas Southwestern Medical Center Dallas, TX Michele L. Pearson, MD (Executive Secretary) Centers for Disease Control and Prevention Atlanta, GA Raymond Y.W. Chinn, MD Sharp Memorial Hospital San Diego, CA Alfred DeMaria, Jr, MD Massachusetts Department of Public Health Jamaica Plain, MA James T. Lee, MD, PhD University of Minnesota Minneapolis, MN William A. Rutala, PhD, MPH University of North Carolina Health Care System Chapel Hill, NC William E. Scheckler, MD University of Wisconsin Madison, WI Beth H. Stover, RN Kosair Children’s Hospital Louisville, KY Marjorie A. Underwood, RN, BSN CIC Mt. Diablo Medical Center Concord, CA This guideline discusses use of products by healthcare personnel in healthcare settings such as hospitals, ambulatory care and home care; the recommendations are not intended for consumer use of the products discussed. 2